SEP
VCYT icon

Signature Equity Partners’s Veracyte VCYT Stock Holding History

Signature Equity Partners’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.41K Hold
24
– – ﹤0.01% 1242
2026
Q1 		$773 Hold
24
– – ﹤0.01% 1311
2025
Q4 		$1.01K Buy
+24
New +$967 ﹤0.01% 1390

Other funds holding VCYT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Signature Equity Partners's VCYT Position: Q2 2026 in Review

Signature Equity Partners held its Veracyte (VCYT) position steady in Q2 2026 at 24 shares worth $1.41K. The position accounts for ﹤0.01% of the portfolio, ranked #1242.

Signature Equity Partners first reported a position in VCYT in Q4 2025 and has held it in 3 quarters since. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Signature Equity Partners held 24 shares of Veracyte worth $1.41K as of Q2 2026.
  • Signature Equity Partners left its Veracyte share count unchanged in Q2 2026.
  • Veracyte made up ﹤0.01% of Signature Equity Partners's portfolio in Q2 2026, its #1242 holding.
  • Signature Equity Partners first reported a position in Veracyte in Q4 2025 and has held it in 3 quarters since.
  • 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Signature Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.